Steven Kanner, Chief Scientific Officer at Caribou Biosciences, Inc. (CRBU), bought 214,408 shares at $1.81 ($401K) on 2021-10-12, disclosed to the SEC on 2021-10-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.81 | 698 | $1K | 0.3% |
| 2 | $1.81 | 99,548 | $180K | 44.9% |
| 3 | $1.81 | 99,548 | $180K | 44.9% |
| 4 | $2.69 | 14,614 | $39K | 9.8% |
| Total | $1.87 avg | 214,408 | $401K | 100% |
| Filing → |